Literature DB >> 10085135

Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.

P Stathakis1, A J Lay, M Fitzgerald, C Schlieker, L J Matthias, P J Hogg.   

Abstract

Plasmin is processed in the conditioned medium of HT1080 fibrosarcoma cells producing fragments with the domain structures of the angiogenesis inhibitor, angiostatin, and microplasmin. Angiostatin consists of kringle domains 1-4 and part of kringle 5, while microplasmin consists of the remainder of kringle 5 and the serine proteinase domain. Our findings indicate that formation of angiostatin/microplasmin involves reduction of plasmin by a plasmin reductase followed by proteolysis of the reduced enzyme. We present evidence that the Cys461-Cys540 and Cys511-Cys535 disulfide bonds in kringle 5 of plasmin were reduced by plasmin reductase. Plasmin reductase activity was secreted by HT1080 and Chinese hamster ovary cells and the human mammary carcinoma cell lines MCF-7, MDA231, and BT20 but not by the monocyte/macrophage cell line THP-1. Neither primary foreskin fibroblasts, blood monocyte/macrophages, nor macrovascular or microvascular endothelial cells secreted detectable plasmin reductase. In contrast, cultured bovine and rat vascular smooth muscle cells secreted small but reproducible levels of plasmin reductase. Reduction of the kringle 5 disulfide bonds triggered cleavage at either Arg529-Lys530 or two other positions C-terminal of Cys461 in kringle 5 by a serine proteinase. Plasmin autoproteolysis could account for the cleavage, although another proteinase was mostly responsible in HT1080 conditioned medium. Three serine proteinases with apparent Mr of 70, 50, and 39 were purified from HT1080 conditioned medium, one or more of which could contribute to proteolysis of reduced plasmin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085135     DOI: 10.1074/jbc.274.13.8910

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Purification and characterization of ovotransferrin from Crocodylus siamensis.

Authors:  Sukanya Chaipayang; Napus Heamatorn; Likhid Keha; Sakda Daduang; Chomphunuch Songsiriritthigul; Prasan Swatsitang; Apisak Dhiravisit; Sompong Thammasirirak
Journal:  Protein J       Date:  2013-02       Impact factor: 2.371

Review 2.  Control of blood proteins by functional disulfide bonds.

Authors:  Diego Butera; Kristina M Cook; Joyce Chiu; Jason W H Wong; Philip J Hogg
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

3.  Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.

Authors:  Diego Butera; Troels Wind; Angelina J Lay; Julia Beck; Francis J Castellino; Philip J Hogg
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

4.  Specific conformational changes of plasminogen induced by chloride ions, 6-aminohexanoic acid and benzamidine, but not the overall openness of plasminogen regulate, production of biologically active angiostatins.

Authors:  Debra J Warejcka; Sally S Twining
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

5.  Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.

Authors:  S Gyorffy; K Palmer; J Gauldie
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 6.  Formation, reactivity, and detection of protein sulfenic acids.

Authors:  Nicholas J Kettenhofen; Matthew J Wood
Journal:  Chem Res Toxicol       Date:  2010-09-16       Impact factor: 3.739

7.  Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin.

Authors:  Iman Azimi; Lisa J Matthias; Rob J Center; Jason W H Wong; Philip J Hogg
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

8.  The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.

Authors:  S Dedieu; X Canron; H R Rezvani; M Bouchecareilh; F Mazurier; R Sinisi; M Zanda; M Moenner; A Bikfalvi; S North
Journal:  BMC Med       Date:  2010-03-24       Impact factor: 8.775

9.  The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.

Authors:  Oskar Eriksson; Margareta Ramström; Katarina Hörnaeus; Jonas Bergquist; Dariush Mokhtari; Agneta Siegbahn
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

10.  Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice.

Authors:  Francesca Margheri; Simona Serratì; Andrea Lapucci; Chillà Anastasia; Betti Giusti; Marco Pucci; Eugenio Torre; Francesca Bianchini; Lido Calorini; Adriana Albini; Agostina Ventura; Gabriella Fibbi; Mario Del Rosso
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.